121
triamcinolone for refractory diabetic macular edema: a randomized clíni-
cal trial. Eur J Ophthalmol. 2005;15(6):746—50
7.
Chew E, Strauber S, Beck R, et al. Randomized trial of peribulbar triamci-
nolone acetonide with and without focal photocoagulation for mild dia-
betic macular edema: a pilot study. Ophthalmology. 2007;114(6):1190-6.
8.
Mark C Gilles, Yan L MacAlister et al. Intravitreal TC prior to laser treat-
ment of DME. 24-months result, a randomized controlled trial.Ophthal-
mology 2011;118:866–872.
9.
Five years result of a randomized trial with open label extension of TC
for refractory diabetic macular edema.Ophthalmology 2009;116:2182–
2187.
10.
Gillies MC, Simpson JM, Gaston C, et al. Five-year results of a randomi-
zed trial with open-label extension of triamcinolone acetonide for refrac-
tory diabetic macular edema. Ophthalmology 2009;116:2182–7.
11.
Taygan Ylmaz,Christopher D Weaver et al. Intravitreal Triamcinolone
Acetonide Injection for Treatment of Refractory Diabetic Macular Edema.
A Systematic Review. Ophthalmology 2009;116:902–913.
12.
Diabetic Retinopathy Clínical Research Network, Beck RW, Edwards AR,
Aiello LP, et al. Three-year follow-up of a randomized trial comparing
focal/grid photocoagulation and intravitreal triamcinolone for diabetic
macular edema. Arch Ophthalmol. 2009;127(3):245-251.
13.
Diabetic Retinopathy Clínical Research Network, Elman MJ, Aiello LP,
Beck RW, et al. Randomized trial evaluating ranibizumab plus prompt
or deferred laser or triamcinolone plus prompt laser for diabetic macular
edema. Ophthalmology. 2010;117(6):1064-1077.
14.
Diabetic Retinopathy Clínical Research Network, Elman MJ, Aiello LP,
Beck RW, et al. Rationale for Diabetic Retinopathy Clínical Reshearch
Network Treatment Protocol for Center-Involved Diabetic Macular Ede-
ma. Ophthalmology 2011;118:e5-e14.
15.
Vinay Dewan, Dennis Lambert e tal. Cost Effectiveness Analysis of Rani-
bizumab plus Promp or deffered Laser or TC plus Prompt or Differed
Laser. Ophthalmology 2012;119:1679-1684.
16.
Jennifer I Lim, Anne E Fung and al., Sustained-release intravitreal liquid
drug delivery using triamcinolone acetonide for cistoid macular edema in
retinal vein occlusion.Ophthalmology 2011;118:1416-1422.
17.
Kuppermann BD, Blumenkranz MS, Haller JA, et al; Dexamethasone
DDS Phase II Study Group. Randomized controlled study of an intravi-
treous dexamethasone drug delivery system in patients with persistent
macular edema. Arch Ophthalmol. 2007;125(3):309-317.
18.
Haller JA, Kuppermann BD, Blumenkranz MS, et al; Dexamethasone
DDS Phase II Study Group. Randomized controlled trial of an intravi-
treous dexamethasone drug delivery system in patients with diabetic
macular edema. Arch Ophthalmol. 2010;128(3):289-296.
19.
Boyer DS, Faber D, Gupta S, et al; for the Ozurdex CHAMPLAIN Stu-
dy Group. Dexamethasone intravitreal implant for treatment of diabetic
macular edema in vitrectomized patients. Retina 2011; 31:915-923.